Clariant stock gained 1.15 percent as Stahl deal released cash

Published on 10/04/2026 at 15:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Clariant stock now has preliminary CHF 220 million cash proceeds from the Stahl transaction dated October 1, 2026. H1 EBITDA fell 7.7 percent to CHF 331 million.

Clariant AG (CH0012142631) - Architektur-Render — Clariant AG (CH0012142631) zeigt gläserne Firmenzentrale als architektonisches Render mit klaren Linien und modernem Design, Illustration mit AI erstellt.

Clariant (ISIN CH0012142631) stock was last at CHF 10.57 on SIX on October 2, 2026 at 5:30 p.m. CEST, up 1.15 percent on the session. The company has also secured preliminary cash proceeds of CHF 220 million before tax from the completed Stahl transaction, giving the stock a fresh balance-sheet catalyst.

Stahl stake brings CHF 220 million

According to Clariant on October 1, 2026, the specialty chemicals group held a 14.6 percent minority stake in Stahl Group. The closing between Wendel and Henkel triggers preliminary cash proceeds of CHF 220 million before tax for Clariant.

The proceeds matter because they arrive alongside a portfolio focused on specialty chemicals rather than a fresh operating acquisition. The cash payment is preliminary and before tax, so its eventual contribution to earnings and capital allocation remains a separate question from the transaction closing itself.

H1 sales hold while EBITDA falls

Clariant's H1 2026 sales reached CHF 1,859 million, flat in local currency excluding portfolio pruning and down 1.2 percent when those measures are included. Yahoo Finance reported that EBITDA before exceptional items declined 7.7 percent year over year to CHF 331 million, with the margin at 17.8 percent versus 18.1 percent.

The split between business units is important for the next earnings checkpoint. Care Chemicals grew 2.3 percent in local currency excluding portfolio pruning, while Catalysts declined 8.3 percent and Adsorbents and Additives increased 1.3 percent in the first half.

Management kept its 2026 guidance for sales at 2025 levels in local currency and an EBITDA margin of 18 percent before exceptional items. The H1 margin of 17.8 percent leaves operating execution and the recovery of Catalysts volumes central to the full-year outcome.

Consensus target stays below the price

According to MarketScreener, the consensus rating is Outperform from 16 analysts, with an average target of CHF 10.41. The target lies 1.5 percent below the October 2 price of CHF 10.57, a modest gap that places the cash proceeds and the Catalysts recovery at the center of the valuation debate.

The next reported checkpoint is scheduled for November 2, 2026, when Clariant is due to publish its third-quarter 2026 earnings. That date will test whether pricing, cost savings and improving customer activity can offset the pressure seen in Catalysts during the first half.

Clariant stock holds above CHF 10

Clariant stock was last at CHF 10.57 on SIX on October 2, 2026 at 5:30 p.m. CEST, compared with a 52-week range of CHF 6.55 to CHF 11.04 and market capitalization of CHF 3.5 billion. The session volume was 468,456 shares.